Skip to main content

7 Result(s)

within Luigi Maiorino Remove this filter

and

  1. Article

    Open Access

    Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

    The effect of the addition of fotemustine and/or interferon (IFN) to standard therapy with dacarbazine alone in patients with advanced malignant melanoma was investigated in a multicenter, randomized 2x2 facto...

    Antonio Daponte, Simona Signoriello, Luigi Maiorino… in Journal of Translational Medicine (2013)

    Download PDF (738 KB) View Article

  2. No Access

    Article

    Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study

    Advanced hepatocellular carcinoma (HCC) not eligible for local therapies has limited chances of cure. Sorafenib is a multikinase inhibitor with proven activity in advanced HCC. Octreotide is used in this setti...

    Salvatore Del Prete, Liliana Montella… in Cancer Chemotherapy and Pharmacology (2010)

  3. No Access

    Article

    Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series

    The survival of patients with hepatocellular carcinoma (HCC) has improved with advancements in various diagnostic tools and treatment modalities. Consequently, bone metastases from HCC are diagnosed more frequ...

    Liliana Montella, Raffaele Addeo… in Cancer Chemotherapy and Pharmacology (2010)

  4. No Access

    Article

    Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group

    This phase II trial assessed the tolerability and efficacy of a triplet of oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer.

    Pasquale Comella, Vito Lorusso, Luigi Maiorino… in Cancer Chemotherapy and Pharmacology (2009)

  5. No Access

    Article

    Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401

    Oxaliplatin combined with either fluorouracil/leucovorin (OXAFAFU) or capecitabine (OXXEL) has a demonstrated activity in metastatic colorectal cancer patients. We aimed at comparing these two regimens in term...

    Pasquale Comella, Bruno Massidda… in Journal of Cancer Research and Clinical On… (2009)

  6. No Access

    Article

    Cisplatin–epirubicin–paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study

    Purpose.It has been shown in vitro that both cisplatin and epirubicin increase the antitumor activity of paclitaxel. Weekly administration could give a substantial improvement in the therapeutic index of cisplat...

    Giuseppe Frasci, Giuseppe D'Aiuto, Pasquale Comella… in Breast Cancer Research and Treatment (2000)

  7. No Access

    Article

    Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study

    Purpose: In a previous phase I study we found the MTDs of paclitaxel and cisplatin when given together weekly, with or without G-CSF support, in patients with advanced solid tumors. The present study was conducte...

    Giuseppe Frasci, Pasquale Comella, Giuseppe D'Aiuto… in Breast Cancer Research and Treatment (1998)